| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 82058-27-3 | 3,7-diazabicyclo(3.3.1)nonane-3-carboxamide, n-tert-butyl-9-oxo-2,4,6,8-tetraph | |
| |
| 82058-26-2 | n-butyl-9-oxo-2,4,6,8-tetraphenyl-7-diazabicyclo(3.3.1)nonane-3-carboxamide | |
| |
| 82058-25-1 | n-ethyl-9-oxo-2,4,6,8-tetraphenyl-7-diazabicyclo(3.3.1)nonane-3-carboxamide | |
| |
| 82057-27-0 | 3h)-pyrimidinedione, dihydro-1-(1-(3-phenyl-2-propenyl)-4-piperidinyl)-4(1h | |
| |
| 82056-50-6 | ducts with epichlorohydrin | |
| |
| 82050-51-9 | to 115 | |
| |
| 82049-30-7 | 5-phenyl-thianthreniu hexafluorophosphate(1-) | |
| |
| 82049-08-9 | 1,2:3,6-dianhydro-galactito | |
| |
| 82048-97-3 | angiotensinogen fragment 1-13 human | |
C79H116N22O17 | 1645.92 |
| 82042-38-4 | benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxole-5,6-diol, 5,6,7,8-tetrahydro-6,7-di | |
| |
| 82039-96-1 | 1-(5-nitro-4-imidazolyl)-3-triazenediethanol | |
| |
| 82039-95-0 | 4-(3,3-diethyl-1-triazenyl)-5-nitro-1h-imidazol | |
| |
| 82039-94-9 | 4-(3,3-dimethyl-1-triazenyl)-5-nitro-1h-imidazol | |
| |
| 82039-90-5 | 5-amino-4-nitroimidazole | |
C3H4N4O2 | 128.09 |
| 82039-83-6 | 4-(hydroperoxyacetyl)-3-methyl-2-benzofurancarboxylic aci ethyl ester | |
| |
| 82039-82-5 | 5-(hydroperoxyacetyl)-3-(p-toluoyl)-benzofura | |
| |
| 82039-81-4 | ketone, 3-benzoylbenzofuran-5-yl hydroperoxymethyl | |
| |
| 82039-79-0 | 3-benzofurancarboxylic acid, 6-bromo-5-(hydroperoxyacetyl)-2-((phenylthio)methy | |
| |
| 82038-92-4 | guanidine, 2-cyano-1,3-dinitroso-3-methyl-1-(2-(((4-methyl-4-imidazolin-5-yl)me | |
| |
| 82034-46-6 | loteprednol etabonate | 熔点：220.5-223.5°C
沸点：600.1°C
|
C24H31ClO7 | 466.95 |
| 82033-15-6 | ammonium, (18,20-dihydroxypregnane-3,16-diyl)bis(trimethyl-, diiodide, diacetat | |
| |
| 82032-43-7 | hydroxymethylimidazolecarboxylicacidmethylester | 熔点：173°C
|
C6H8N2O3 | 156.14 |
| 82030-87-3 | n-l-methionyl-somatotropin (human | |
| |
| 82030-85-1 | 全氟烷基(C4-C14)羰基氨基甲氧基聚环氧乙烷
Perfluoroalkyl(C4-C14) carbonyl aminomethoxy polyethylene oxide | |
| |
| 82030-84-0 | 全氟烷基(C4-C14)羰基氨基丙基二甲基氧化胺
Perfluoroalkyl(C4-C14)carbonyl aminopropyl dimethylamine oxide | |
| |
| 82030-83-9 | N,N-二甲基-N-(全氟烷基(C4-C14)羰基氨基丙基)-α-乙酸甜菜碱
N,N-Dimethyl-N-(perfluoroalkyl(C4-C14)carbonyl aminopropyl)-.alpha.-acetic acid betaine | |
| |
| 82030-81-7 | 全氟烷基(C4-C14)羰基氨基丙基三甲基碘化铵
Perfluoroalkyl(C4-C14)carbonyl aminopropyl trimethyl ammonium iodide | |
| |
| 82030-16-8 | antibiotic i-1 | |
| |
| 82029-16-1 | antibiotic 8006-i | |
| |
| 82027-60-9 | [μ-[[3,3'-氧偶氮基双[6-[2-[4-[[3-羟基-4[(2-羟基-5-磺酸苯基)偶氮]苯基]偶氮]-2-磺酸苯基]乙烯基]苯磺酸合]](6-)]]二铜酸六钠
Cuprate(6-), [μ-[[3,3'-azoxybis[6-[2-[4-[[3-hydroxy-4-[(2-hydroxy-5-sulfophenyl) azo]phenyl]azo]-2-sulfophenyl] ethenyl] benzenesulfonato]](6-)]]di-, hexasodium | |
| |
| 82027-59-6 | copper(from triethanolamine complex) | |
| |
| 82027-58-5 | scombrotoxin | |
| |
| 82024-14-4 | n-butyl-4-((1-oxobutyl)amino)-pentanamid | |
| |
| 82024-13-3 | n-butyl-3-((1-oxobutyl)amino)-butanamid | |
| |
| 82024-11-1 | n-(3-(dibutylamino)-3-oxopropyl)-2,2-dimethyl-propanamid | |
| |
| 82024-09-7 | n-(3-(dibutylamino)-3-oxopropyl)-butanamid | |
| |
| 82024-08-6 | n-(3-(butylamino)-3-oxopropyl)-butanamid | |
| |
| 82024-05-3 | n-butyl-4-((2-methyl-1-oxopropyl)amino)-butanamid | |
| |
| 82024-04-2 | n,n-dibutyl-4-((2-methyl-1-oxopropyl)amino)-butanamid | |
| |
| 82024-03-1 | n-(4-butylamino-4-oxobutyl)-cyclopropanecarboxamid | |
| |
| 82024-01-9 | 3-methyl-n-(4-oxo-4-(propylamino)butyl)-butanamid | |
| |
| 82024-00-8 | n-(4-(butylamino)-4-oxobutyl)-3-methyl-butanamid | |
| |
| 82023-97-0 | n,n-dibutyl-4-((2,2-dimethyl-1-oxopropyl)amino)-butanamid | |
| |
| 82023-96-9 | n-butyl-4-((2,2-dimethyl-1-oxopropyl)amino)-butanamid | |
| |
| 82023-94-7 | n-(1,1-dimethylpropyl)-4-((1-oxobutyl)amino)-butanamid | |
| |
| 82023-91-4 | n,n-dipentyl-4-((1-oxobutyl)amino)-butanamid | |
| |
| 82023-90-3 | n-hexyl-4-((1-oxobutyl)amino)-butanamid | |
| |
| 82023-86-7 | n-ethyl-4-((1-oxobutyl)amino)-butanamid | |
| |
| 82023-85-6 | 4-((1-oxobutyl)amino)-n-propyl-butanamid | |
| |
| 82023-83-4 | 4-((1-oxobutyl)amino)-n-(phenylmethyl)-butanamid | |
| |
